Fred Hutch and UW Medicine reseracher and physicians

Since its designation as a National Cancer Institute (NCI) Comprehensive Cancer Center in 1973, the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium has demonstrated a commitment to excellence in cancer research and treatment. The purpose of the Consortium is to bring together cancer-focused researchers from across its three participating institutions. Through efforts to promote collaboration and support research among its members, the Cancer Consortium aims to increase understanding, strengthen prevention and diagnostic capabilities, and develop effective therapies for cancer.

The Consortium comprises over 650 faculty from a variety of backgrounds and disciplines, including basic science, clinical and translational research, and public health. 

Our Focus

The Consortium’s efforts are centered around five strategic areas of research:

Molecular Basis of Cancer

Leverage Consortium expertise in cancer biology, computational biology, and epigenetics to advance cancer diagnostics and treatment.

Immunology & Transplantation

Build on the Consortium’s historical strength to focus on next generation immunotherapeutic treatments such as T cell immunotherapy and therapeutic vaccines.

Pathogen Associated Malignancies

Further our understanding of the role played by bacterial or viral agents in cancer and develop approaches to both prevention and therapy, as well as implement public health measures directed at eliminating pathogen associated malignancies.

Tumor Site-Specific Translational Research

Deepen our knowledge of the development and progression of individual tumor types and utilize our extensive laboratory and clinical insights to improve therapies.

Cancer Etiology, Prevention & Outcomes

Quantify and reduce the burden of cancer across the entire disease spectrum by building on the work ongoing in programs such as the Women’s Health Initiative and Hutchinson Institute for Cancer Outcomes Research (HICOR).

Our Approach

The Consortium comprises eight different research programs, each of which address a different aspect or area of cancer research. The Consortium also supports and collaborates with a variety of other programs and organizations that provide resources to members and further our research aims, including the Office of Community Outreach & Engagement (OCOE), Office of Education and Training (OET), the Office of Facuty Affairs and Diversity (OFAD), and twelve sponsored Shared Resources.

Cancer Center Support Grant (CCSG)

The Fred Hutch/University of Washington/Seattle Children's Cancer Consortium receives a P30 Cancer Center Support Grant and accompanying NCI designation for successfully meeting a spectrum of rigorous competitive standards associated with scientific and organizational merit. The CCSG supports research infrastructure that enhances collaborative, transdisciplinary research productivity. CCSG grants provide funding for formalized cancer research programs, shared research resources, scientific and administrative management, planning and evaluation activities, development of new scientific opportunities, and centralized clinical trial oversight and functions.

Award Details

  • Grant #:  NCI 5 P30 CA015704-48
  • Principal Investigator:  Thomas J. Lynch Jr., MD
  • Current Budget Period:  1/1/2023 - 12/31/2023
  • Project Period:  1/1/1997 - 12/31/2024
  • Current Direct Cost Award:  $ 6,369,978
  • Current Total Cost Award:  $ 10,090,142
  • Total Direct Costs for Current Project Period:  $ 31,849,900
  • Total Costs for Current Project Period:  $ 50,830,713

Our Impact

graphic of the globe

The Cancer Consortium is dedicated to eliminating cancer as a cause of suffering and death, both locally and around the world. Through close collaboration with our Office of Community Outreach & Engagement (OCOE), Consortium faculty are able to tailor their research and work to the needs of the communities in our Catchment Area, which encompasses the entire state of Washington.

In addition to our Catchment Area, the Consortium is proud to serve as the central node of a widespread research network that includes over 1,000 research sites in more than 70 countries, most notably the Uganda Cancer Institute in Kampala, Uganda. 

Citing the CCSG

All publications, press releases, or other documents that cite results from CCSG-supported research must include acknowledgment of the grant and maintain compliance with NIH Public Access Policy.  All manuscripts accepted for publication must be submitted to PubMed Central and be assigned a PMCID.

Recommended language:

This research was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA015704.

or, if the publication resulted from the use of one or more Shared Resources:

This research was supported by the [insert name] Shared Resource of the Fred Hutch/University of Washington/Seattle Children's Cancer Consortium (P30 CA015704).

Contact Us

Contact Cancer Consortium Administration with questions about the CCSG, obtaining a PMCID, or citing the grant.

A complete listing of CCSG-Supported Shared Resources can be found here.